Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
Nat Commun
; 8: 14454, 2017 02 14.
Article
in En
| MEDLINE
| ID: mdl-28195574
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dystrophin
/
Muscular Dystrophy, Duchenne
/
CRISPR-Cas Systems
/
Gene Editing
Limits:
Animals
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2017
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido